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By Jack James*
History of The Crisis
It is no secret that the United States is in the midst of an Opioid Crisis (the
“Crisis”). What may surprise some, however, is that the Crisis has actually
been going on for decades. The problem originated in the late 1990s when
pharmaceutical companies reassured the medical community that their
opioid pain relievers were not addictive, which led physicians to prescribe
them at greater rates.1 Widespread misuse and diversion2 of these
medications followed as a result, all before it became clear that they could,
in fact, be highly addictive.3 These harmful practices continued over the
next twenty years with heroin and synthetic opioids, such as fentanyl,
contributing to the devastation.4 Today, the Crisis has shown no signs of
slowing down, with over 130 Americans dying every twenty-four hours
from opioid overdoses.5
In addition to the immeasurable amount of heartache the Crisis has brought
families and communities, it has also come with a significant economic cost.
According to a study conducted by the Centers for Disease Control and
Prevention, the total economic burden of prescription opioid misuse alone
in the United States is $78.5 billion annually.6 The public sector bears
approximately one quarter of this cost in the form of health care, substance
abuse treatment, and criminal justice costs.7 The question persists: will the
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1 Opioid Overdose Crisis, National Institute on Drug Abuse, (Revised January, 2019),
https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis.
2 The term “diversion,” refers to the transfer of opioids from the individual for whom they
were prescribed, to others, which is illegal.
3 Id.
4 History of the Opioid Epidemic – How Did We Get Here?, Poison Control, (February 12,
2018), https://www.poison.org/articles/opioid-epidemic-history-and-prescribingpatterns-182.
5 National Institute on Drug Abuse, supra note 1.
6 Id.
7 Id.
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government be forced to pick up the tab for battling the Crisis? Perhaps not.
Thousands of state and local governments have filed complaints against
prescription opioid manufacturers, suppliers, and distributors demanding
compensation for the costs of responding to the Crisis.8 Although the
timelines for these lawsuits vary, the first cases are set to be heard in
courtrooms as early as this year.9
The “Test” Case in Ohio
One of the largest opioid cases is set to take place in federal court this
October in Cleveland, Ohio.10 The case, which is being called one of the most
complicated legal battles in history, consists of hundreds of lawsuits filed
by cities and counties from around the country.11 Rather than naming one
type of industry defendant, this litigation lists several, each playing a
different role – not only drug makers but also distributors and retailers.12
The plaintiffs claim that: manufacturers like Purdue Pharma and Johnson
& Johnson aggressively marketed the pills for years despite knowing about
the addictive properties; distributors like McKesson and Cardinal Health
shipped alarming quantities without reporting to the authorities; and
pharmacy chains like Walgreens and CVS Health looked away while selling
flag-raising amounts of these medications to individuals.13 The legal
theories under which the plaintiffs are suing include public nuisance, fraud,
racketeering and corruption, as well as violations of federal and state laws
covering controlled substances.14
Brian Mann, Opioid-Makers Face Wave of Lawsuits in 2019, NPR (December 31, 2008, 7:00
AM), https://www.npr.org/2018/12/31/680741170/opioid-makers-face-wave-of-lawsuitsin-2019.
9 Id.
10 Jan Hoffman, Opioid Lawsuits are Headed to Trial. Here’s Why the Stakes are Getting Uglier,
The New York Times, (January 30, 2019),
https://www.nytimes.com/2019/01/30/health/opioid-lawsuits-settlement-trial.html.
11 To organize this litigation, these lawsuits were consolidated into one case by the
Judicial Panel on Multidistrict Litigation (“JPML”). Jeremy Nobile, Cleveland court is Big
Pharma’s battleground for opioid liability, Crain’s Cleveland Business (December 8, 2018,
4:00 AM). https://www.crainscleveland.com/legal/cleveland-court-big-pharmasbattleground-opioid-liability.
12 Jan Hoffman, Can This Judge Solve The Opioid Crisis?, The New York Times (March 5,
2018), https://www.nytimes.com/2018/03/05/health/opioid-crisis-judge-lawsuits.html.
13 Id.
14 Id.
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The defendants have pushed back in response to the allegations, claiming
that the Crisis was caused by a number of factors.15 The defendant
companies challenge state liability for actions concerning the use of
prescription opioids marketed and overseen by the Food and Drug
Administration (the “FDA”), the governing body “specifically authorizing”
such actions.16 The defendants have also argued that much of the misuse of
prescription and illicit opioids is attributable to downstream actors who are
far outside of the companies’ control.17 Finally, manufacturers such as
Purdue Pharma have changed their marketing strategies by ceasing the
practice of promoting opioid medications to prescribers.18 Purdue Pharma
has even started allocating funds to support prescription drug education
around the country and has run full-page ads in national publications
outlining these efforts.19 Yet, this has done little to silence the critics. In an
interview earlier this year, Mike Dewine, the Ohio Attorney General, voiced
his unenthusiastic impression of these efforts in saying, “They can put as
many ads as they want out there, but that’s not dealing with the problem.”20
While on paper it may appear that these parties are on a collision course to
meet at trial, the matter will likely never make it there. During the first
hearing for the case, U.S. District Judge Dan Polster informed lawyers on
both sides that he intended to dispense with legal norms such as discovery
and would not preside over years of “unraveling complicated conspiracy
theories.”21 He then ordered each side to prepare for settlement discussions
immediately.22 In the past, drug makers and distributors have refuted
demands of the plaintiffs in the hopes of either narrowing or defeating the

Mann, supra note 8.
Paul Schott, Opioid crisis fuels massive litigation against Purdue Pharma, Stamford
Advocate (November 2, 2018 4:52 PM),
https://www.stamfordadvocate.com/business/article/Opioid-crisis-fuels-massivelitigation-against-13358809.php.
17 See id.
18 Mann, supra note 8.
19 Schott, supra note 16.
20 Id.
21 Id.
22 Id.
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lawsuits in order to mitigate any settlement costs.23 Aware of this, Judge
Polster reminded the defendants that if they choose to resist a swift
settlement in favor of litigation, they could be setting themselves up for an
unpredictable jury trial.24
Potential Impact
With this being one of the first cases of its kind, the implications could be
significant. Other opioid lawsuits around the country are vastly similar,
and the outcome of this case will likely serve as a bellwether for how future
cases could play out.25 If the parties settle as expected, the combined amount
agreed upon between this case and the lawsuits to follow could reach an
unprecedented height. Public officials hope for an outcome similar to the
massive tobacco settlement of 1998 worth nearly $250 billion.26 However, to
cover the costs of the Crisis, such a settlement could amount to several times
that.27 In Judge Polster’s words, not a settlement that would “just be moving
money around,” but one that “would provide meaningful solutions to a
national crisis.”28 Local and state officials have echoed his sentiment, saying
that they desperately need that kind of cash settlement to solve the crisis.29
A settlement worth hundreds of billions of dollars could revolutionize the
national response, supporting more drug rehab programs, detox beds, and
training for first responders.30
Unfortunately, such a settlement does not appear imminent.31 Even if the
parties were to enter into any major agreements, Purdue Pharma and other
defendants are expected to demand that they would not be liable for any
actions predating the settlement.32 This provision is crucial to the companies
Alex Keown, A Test for Opioid Lawsuits, Ohio Case is Pushed Forward by Magistrate,
BioSpace, October 8, 2018), https://www.biospace.com/article/a-test-for-opioid-lawsuitsohio-case-is-pushed-forward-by-magistrate/.
24 Hoffman, supra note 12.
25 Nobile, supra note 11.
26 Schott, supra note 16.
27 Id.
28 Hoffman, supra note 12.
29 Mann, supra note 8.
30 Id.
31 Schott, supra note 16.
32 Id.
23

SAINT LOUIS UNIVERSITY LAW JOURNAL ONLINE

because if there is an “escape hatch” in the agreement, the companies are
presumably paying billions of dollars to be sued again later on.33 Still, with
the exception of the defendants, most people are hopeful that settlements
come sooner rather than later.34 Dr. Jeff Gordon, a former president of the
Connecticut State Medical Society, affirmed this notion in a recent
interview: “The reality is these lawsuits take years, and years is not
something we have. We need to deal with this problem now.”35
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